Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Isotopes and Radioisotopes

Isotopes and Radioisotopes

In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery Platform.

Journal of medicinal chemistry·2019

Same author

Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.

Molecular pharmaceutics·2016

Same author

The dendrimer paradox--high medical expectations but poor clinical translation.

Chemical Society reviews·2015

Same author

What nanomedicine in the clinic right now really forms nanoparticles?

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2014

Same author

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

Journal of controlled release : official journal of the Controlled Release Society·2011

Same author

Dendrimers as versatile platform in drug delivery applications.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2008

Search research articles

Related Experiment Video

Updated: May 14, 2026

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Theranostics: are we there yet?

Sonke Svenson¹

¹Drug Delivery Solutions LLC, 16 Temple Street, Arlington, Massachusetts 02476, USA. ssvenson@drugdeliverysolution.com

Molecular Pharmaceutics

|February 6, 2013

Summary

Nanotechnology offers promising theranostic nanocarriers for cancer treatment, combining diagnostics and therapeutics. Carefully designed polymers show advantages for clinical translation over random entrapment methods.

Area of Science:

Biomedical Engineering
Nanotechnology
Oncology

Background:

The National Cancer Institute aims to eliminate cancer by 2015.
Nanotechnology-based therapeutics are crucial for achieving this goal.
Theranostic nanocarriers integrate diagnostic and therapeutic functions.

Purpose of the Study:

To evaluate different theranostic nanocarrier approaches for cancer therapy.
To determine the most promising strategies for clinical translation.
To assess the advantages of polymer-based nanocarriers.

Main Methods:

Review of various nanocarrier delivery systems (prodrugs, liposomes, polymersomes, micelles, nanoparticles).
Analysis of agent conjugation and entrapment methods.

More Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: May 14, 2026

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Comparison of passive and active targeting strategies.

Main Results:

Carefully designed polymers offer advantages for theranostic nanocarrier development.
Passive targeting via the EPR effect is dominant in current nanocarrier formulations.
The necessity of active targeting ligands for EPR-effect-based nanocarriers requires further demonstration.

Conclusions:

While no single approach guarantees immediate clinical success, advanced polymer-based theranostic nanocarriers show significant potential.
Further research is needed to optimize nanocarrier design for enhanced efficacy and regulatory approval.
Promising nanotechnology-based approaches are being developed for improved cancer patient outcomes.